This inventor holds 4 USPTO granted patents and 4 published patent applications and 2 EPO patents. Top assignees: Roche Nimblegen, Inc., Ventana Medical Systems, Inc.. Active years: 2009-2014.
Company Filing History:
Years Active: 2009-2014
Title: Jason Norton: Innovator in Oligonucleotide Hybridization Probes
Introduction
Jason Norton, an accomplished inventor based in Madison, WI, has made significant contributions to the field of genomic research. With a remarkable portfolio of four patents, he has focused on advancing the methods used in oligonucleotide hybridization, which are essential for both basic and clinical research applications.
Latest Patents
One of Jason's latest patents, the "Optimized Probe Selection Method," provides an innovative approach to optimizing oligonucleotide hybridization probes. This method involves hybridizing serially diluted genomic samples to the oligonucleotide probes on an array, producing signal intensities for each probe. By computationally identifying optimized probes that exhibit signal intensities corresponding to these dilutions, the invention significantly enhances the reproducibility and strength of the probe signals compared to non-optimized probes.
Career Highlights
Throughout his professional journey, Jason has worked with notable companies such as Roche Nimblegen, Inc. and Ventana Medical Systems, Inc. His experience in these organizations has played a crucial role in shaping his expertise and driving his innovative endeavors in genomic research.
Collaborations
Jason has collaborated with various talented individuals in the field, including his coworkers Roland D. Green and Todd Richmond. These collaborations have further enriched his work and contributed to the successful development of his patented technologies.
Conclusion
Jason Norton's ongoing dedication to optimizing oligonucleotide hybridization probes exemplifies the spirit of innovation in the scientific community. As he continues to build upon his achievements, his work promises to have a substantial impact on genomic research methodologies, ultimately benefiting both researchers and clinicians alike.